Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis

Blaser J, Triebel S, Maasjosthusmann U, Romisch J, KrahlMateblowski U, Freudenberg W, Fricke R, Tschesche H (1996)
CLINICA CHIMICA ACTA 244(1): 17-33.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ;
Abstract / Bemerkung
The concentrations of matrix metalloproteinase-l (MMP-1), matrix metalloproteinase-8 (MMP-8), matrix metalloproteinase-9 (MMP-8), lactoferrin and urokinase plasminogen activator (uPA), tissue-type plasminogen activator (tPA) and the inhibitors, tissue inhibitor of metalloproteinase-l (TIMP-1), plasminogen activator inhibitor-1 (PAI-1), plasminogen activator inhibitor (PAI-2), and alpha(2)-macroglobulin in the synovial fluids of patients with rheumatoid arthritis was determined before and during chemical synoviorthesis with a sodium salt of the fatty acids from cod-liver oil (Varicocid). synovial fluids were obtained before treatment from 37 patients with rheumatoid arthritis and, in most cases, at 8 and 24 h after injection of the agent. Well-established ELISAs were used to determine the amounts of all proteins. All patients with rheumatoid arthritis revealed very high levels of metalloproteinases (about 1-15 mu g/ml) in their synovial fluids. During the inflammation inducing treatment the granulocyte enzymes increased. In contrast to this, the level of MMP-1 decreased. All granulocyte-derived enzymes were strongly correlated with each other, whereas their dependence on the granulocyte count was only weak. uPA and PAI-2 showed good correlations with the granulocytes-derived enzymes, but were also only weakly correlating with the cell counts. tPA was not detected by the ELISA used. The proteases, MMP-8, MMP9 and uPA were increased 8 h after the treatment, whereas the specific inhibitors TIMP-1, PAI-1 and PAI-2 showed significant changes only 24 h after the injection. Matrix metalloproteinases are important factors in the pathogenesis of rheumatoid arthritis. The inflammatory activity in the joint could be better correlated to the granulocyte enzymes than to the granulocyte counts. The levels of uPA and PA1-2 are also parallel to the granulocyte enzyme levels and might underly the same regulatory mechanism.
Erscheinungsjahr
Zeitschriftentitel
CLINICA CHIMICA ACTA
Band
244
Zeitschriftennummer
1
Seite
17-33
ISSN
PUB-ID

Zitieren

Blaser J, Triebel S, Maasjosthusmann U, et al. Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis. CLINICA CHIMICA ACTA. 1996;244(1):17-33.
Blaser, J., Triebel, S., Maasjosthusmann, U., Romisch, J., KrahlMateblowski, U., Freudenberg, W., Fricke, R., et al. (1996). Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis. CLINICA CHIMICA ACTA, 244(1), 17-33. doi:10.1016/0009-8981(95)06172-X
Blaser, J., Triebel, S., Maasjosthusmann, U., Romisch, J., KrahlMateblowski, U., Freudenberg, W., Fricke, R., and Tschesche, H. (1996). Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis. CLINICA CHIMICA ACTA 244, 17-33.
Blaser, J., et al., 1996. Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis. CLINICA CHIMICA ACTA, 244(1), p 17-33.
J. Blaser, et al., “Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis”, CLINICA CHIMICA ACTA, vol. 244, 1996, pp. 17-33.
Blaser, J., Triebel, S., Maasjosthusmann, U., Romisch, J., KrahlMateblowski, U., Freudenberg, W., Fricke, R., Tschesche, H.: Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis. CLINICA CHIMICA ACTA. 244, 17-33 (1996).
Blaser, J, Triebel, S, Maasjosthusmann, U, Romisch, J, KrahlMateblowski, U, Freudenberg, W, Fricke, R, and Tschesche, Harald. “Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis”. CLINICA CHIMICA ACTA 244.1 (1996): 17-33.

18 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Gingival crevicular fluid tissue/blood vessel-type plasminogen activator and plasminogen activator inhibitor-2 levels in patients with rheumatoid arthritis: effects of nonsurgical periodontal therapy.
Kurgan Ş, Önder C, Balcı N, Fentoğlu Ö, Eser F, Balseven M, Serdar MA, Tatakis DN, Günhan M., J Periodontal Res 52(3), 2017
PMID: 27781272
The impact of chemical synovectomy with sodium morrhuate on human chondrocytes and cartilage in vitro.
Winkler S, Grässel S, Baier C, Anders S, Lechler P, Grifka J, Schaumburger J., Rheumatol Int 33(5), 2013
PMID: 22983137
Structure of matrix metalloproteinase-3 with a platinum-based inhibitor.
Belviso BD, Caliandro R, Siliqi D, Calderone V, Arnesano F, Natile G., Chem Commun (Camb) 49(48), 2013
PMID: 23660647
Orally active, antimetastatic, nontoxic diphenyl ether-derived carbamoylphosphonate matrix metalloproteinase inhibitors.
Frant J, Veerendhar A, Chernilovsky T, Nedvetzki S, Vaksman O, Hoffman A, Breuer E, Reich R., ChemMedChem 6(8), 2011
PMID: 21656908
Signal transduction and metabolism in chondrocytes is modulated by lactoferrin.
Brandl N, Zemann A, Kaupe I, Marlovits S, Huettinger P, Goldenberg H, Huettinger M., Osteoarthritis Cartilage 18(1), 2010
PMID: 19747587
Synthesis and evaluation of new tripeptide phosphonate inhibitors of MMP-8 and MMP-2.
Agamennone M, Campestre C, Preziuso S, Consalvi V, Crucianelli M, Mazza F, Politi V, Ragno R, Tortorella P, Gallina C., Eur J Med Chem 40(3), 2005
PMID: 15725496
Tumor necrosis factor-alpha increases chemokine gene expression and production in synovial fibroblasts from human temporomandibular joint.
Ogura N, Tobe M, Sakamaki H, Nagura H, Abiko Y, Kondoh T., J Oral Pathol Med 34(6), 2005
PMID: 15946184
Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis.
Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik B, Skowronski J, Chwiecko J., Rheumatology (Oxford) 41(1), 2002
PMID: 11792884
Chemoenzymatic synthesis of functionalized cyclohexylglycines and alpha-methylcyclohexylglycines via Kazmaier-Claisen rearrangement.
Hudlicky T, Oppong K, Duan C, Stanton C, Laufersweiler MJ, Natchus MG., Bioorg Med Chem Lett 11(5), 2001
PMID: 11266157
Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
Goldbach-Mansky R, Lee JM, Hoxworth JM, Smith D, Duray P, Schumacher RH, Yarboro CH, Klippel J, Kleiner D, El-Gabalawy HS., Arthritis Res 2(2), 2000
PMID: 11062605
Autocrine induction of gliostatin/platelet-derived endothelial cell growth factor (GLS/PD-ECGF) and GLS-induced expression of matrix metalloproteinases in rheumatoid arthritis synoviocytes.
Muro H, Waguri-Nagaya Y, Mukofujiwara Y, Iwahashi T, Otsuka T, Matsui N, Moriyama A, Asai K, Kato T., Rheumatology (Oxford) 38(12), 1999
PMID: 10587545

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 8919199
PubMed | Europe PMC

Suchen in

Google Scholar